Peptides derived from the heparin binding domain of fibronectin
AssigneeHisamitsu Pharmaceutical Co., Inc.
InventorsFumio Fukai, Takashi Katayama
Life of this patent
Estimating the term…
Abstract
The biologically active peptide of the invention has a number of amino acids of 30 or less, comprises an amino acid sequence described as SEQ ID NO:13 (Tyr Thr Ile Tyr Val Ile Ala Leu) in the sequence listing and has cell adhesion inhibition activity. The peptide of the invention has short length and, therefore, synthesis and handling of the peptide are easy.
Claims4
A peptide consisting of an amino acid sequence described as sequence ID No:
- 13 in the sequence listing.
A peptide consisting of an amino acid sequence described as sequence ID No. 8 in the sequence listing.
A peptide consisting of an amino acid sequence described as sequence ID No:
- 11 in the sequence listing.
A peptide consisting of an amino acid sequence described as sequence ID No:
- 12 in the sequence listing.
Dependencies are inferred from the claim text.